Missing/wrong data?
Log in to edit
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
scientific article published on 20 October 2017
Author/s
author: Renato Mantegazza, Michael Benatar, Ted Michael Burns, Kimiaki Utsugisawa, Leslie, Stephan Wenninger, James F. Howard, Richard J Barohn, Richard M. Nowak
Work details
Publication date
October 20, 2017
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.